Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode

Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode

Currently, there is a lack of pharmacogenetic research of antipsychotics’ safety in children and adolescents with acute psychotic episodes. Genetic polymorphisms of CYP2D6 and ABCB1 are the most likely candidates for such studies. AIM.To establish possible associations of CYP3A, CYP2D6, ABCB1 polymo...

Full description

Bibliographic Details
Main Authors: D. V. Ivashchenko, N. I. Buromskaya, P. V. Shimanov, D. V. Deitch., K. A. Ryzhykova, Е. A. Grishina, Yu. S. Shevchenko, D. A. Sychev
Format: Article
Language:Russian
Published: Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2019-12-01
Series:Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:
pharmacogenetics, antipsychotics, safety, adolescents, acute psychotic episode
Online Access:https://www.bekhterevreview.com/jour/article/view/312

Internet

https://www.bekhterevreview.com/jour/article/view/312

Similar Items